Methods for improving the therapeutic index for a chemotherapeutic drug Grant US-11878061-B2 United States of America 23 Jan 2024
Methods of treating triple-negative breast cancer using compositions of antibodies and… Grant US-11872205-B2 United States of America 16 Jan 2024
Carrier-binding agent compositions and methods of making and using the same Grant US-11655301-B2 United States of America 23 May 2023
Methods of treating triple-negative breast cancer using compositions of antibodies and… Grant US-11590098-B2 United States of America 28 Feb 2023
Methods of treating cancer with interferon wherein the cancer cells are HLA negative or… Grant US-11571469-B2 United States of America 07 Feb 2023
Carrier-PD-L1 binding agent compositions for treating cancers Grant US-11548946-B2 United States of America 10 Jan 2023
Albumin-PD-1 paclitaxel nanoparticle complex compositions and methods of making and using… Grant US-11433023-B2 United States of America 06 Sep 2022
Methods of treating PD-L1 expressing cancer Grant US-11427637-B2 United States of America 30 Aug 2022
Paclitaxel-albumin-binding agent compositions and methods for using and making the same Grant US-11311631-B2 United States of America 26 Apr 2022
Methods for reducing toxicity of a chemotherapeutic drug Grant US-11305020-B2 United States of America 19 Apr 2022
Carrier-binding agent compositions and methods of making and using the same Grant US-11241387-B2 United States of America 08 Feb 2022
Methods and compositions for targeting t-cell cancers Grant US-11160876-B2 United States of America 02 Nov 2021
Carrier-antibody compositions and methods of making and using the same Grant US-10993911-B2 United States of America 04 May 2021
Carrier-antibody compositions and methods of making and using the same Grant US-10993912-B2 United States of America 04 May 2021
Carrier-antibody compositions and methods of making and using the same Grant US-10966923-B2 United States of America 06 Apr 2021
Lyophilized compositions comprising albumin-rankl or albumin-GD2 paclitaxel nanoparticle… Grant US-10780049-B2 United States of America 22 Sep 2020
Lyophilized compositions comprosing albumin-EGFR paclitaxel nanoparticle complexes Grant US-10780050-B2 United States of America 22 Sep 2020
Albumin-CTLA-4 paclitaxel nanopartilce complex compositions and methods of making and… Grant US-10772833-B2 United States of America 15 Sep 2020
Methods for treating VEGF-expressing cancer using preformed nanoparticle complexes… Grant US-10765741-B2 United States of America 08 Sep 2020
Nanoparticle complexes of albumin, paclitaxel, and panitumumab for treatment of cancer Grant US-10668151-B2 United States of America 02 Jun 2020
Lyophilized compositions comprising albumin-antibody paclitaxel nanoparticle complexes Grant US-10624846-B2 United States of America 21 Apr 2020
Carrier-binding agent compositions and methods of making and using the same Grant US-10618969-B2 United States of America 14 Apr 2020
Methods of using albumin-CD20 paclitaxel nanoparticle complex compositions for treating… Grant US-10610484-B2 United States of America 07 Apr 2020
Methods of making lyophilized compositions comprising albumin-VEGF paclitaxel… Grant US-10596111-B2 United States of America 24 Mar 2020
Methods of using albumin-antibody nanoparticle complex compositions for treating cancer Grant US-10596112-B2 United States of America 24 Mar 2020
Methods of treating cancer using compositions of antibodies and carrier proteins with… Grant US-10561726-B2 United States of America 18 Feb 2020
Nanoparticle complexes of rituximab, albumin and pacltaxel Grant US-10507243-B2 United States of America 17 Dec 2019
Nanoparticle complexes of paclitaxel, alemtuzumab, and albumin Grant US-10493150-B2 United States of America 03 Dec 2019
Methods for treating cancer using nanoparticle complexes of paclitaxel, cetuximab, and… Grant US-10478495-B2 United States of America 19 Nov 2019
Methods for treating cancer using nanoparticle complexes of paclitaxel, rituximab, and… Grant US-10471145-B2 United States of America 12 Nov 2019
Nanoparticle complexes of paclitaxel, cetuximab, and albumin, and methods of making the… Grant US-10441656-B2 United States of America 15 Oct 2019
Methods for treating CD52-expressing cancers using compositions comprising nanoparticle… Grant US-10420839-B2 United States of America 24 Sep 2019
Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and… Grant US-10413606-B2 United States of America 17 Sep 2019
Carrier-antibody compositions and methods of making and using the same Grant US-10391055-B2 United States of America 27 Aug 2019
Nanoparticle complexes of albumin, paclitaxel, and anti-VEGF antibody for treatment of… Grant US-10376579-B2 United States of America 13 Aug 2019
Methods of treating cancer with antibody-albumin nanoparticle complexes comprising albumin… Grant US-10376580-B2 United States of America 13 Aug 2019
Carrier-antibody compositions and methods of making and using the same Grant US-10322084-B2 United States of America 18 Jun 2019
Nanoparticle complexes of paclitaxel, cetuximab, and albumin Grant US-10307482-B2 United States of America 04 Jun 2019
Carrier-antibody compositions and methods of making and using the same Grant US-10300016-B2 United States of America 28 May 2019
Antibody-albumin nanoparticle complexes comprising albumin, bevacizumab, and paclitaxel… Grant US-10279036-B2 United States of America 07 May 2019
Nanoparticle complexes of paclitaxel, trastuzumab, and albumin Grant US-10279035-B2 United States of America 07 May 2019
Nanoparticle complexes of anti-CD20 antibodies, albumin and paclitaxel Grant US-9757453-B2 United States of America 12 Sep 2017
COMBINATION THERAPY FOR TREATMENT OF CANCER Application US-20140080760-A1 United States of America 20 Mar 2014